(QUBT) Quantum Computing - Ratings and Ratios
Photonic Chip, Entropy Computer, Edge Reservoir, Quantum Authentication
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 96.1% |
| Value at Risk 5%th | 131% |
| Relative Tail Risk | -17.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | -25.79 |
| CAGR/Max DD | 1.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.366 |
| Beta | 2.268 |
| Beta Downside | 2.195 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.89% |
| Mean DD | 53.59% |
| Median DD | 55.28% |
Description: QUBT Quantum Computing January 12, 2026
Quantum Computing Inc. (NASDAQ: QUBT) is an integrated-photonics firm that builds quantum hardware for U.S. commercial and government customers. Its product suite centers on thin-film lithium-niobate (LiNbO₃) chips that enable electro-optical modulators, frequency-conversion devices, and micro-ring resonator cavities. The company’s flagship “entropy quantum computer” delivers a full-stack solution that abstracts away low-level SDK development, exposing API-driven quantum-ready applications. Complementary offerings include a re-programmable reservoir-computing edge chip for recurrent neural-network workloads, a lidar system designed for high-visibility operation in fog, snow, ice or water, a quantum photonic vibrometer for remote vibration sensing, and quantum-network and authentication modules.
From a market perspective, the global quantum-hardware industry is projected to exceed $5 billion by 2028, driven by escalating U.S. federal R&D budgets (the 2023 National Quantum Initiative Act allocated $1.2 billion) and growing demand for secure communications. QUBT’s focus on LiNbO₃ photonics aligns with a sector-wide shift toward low-loss, high-bandwidth optical components, where average wafer yields have risen to ~85 % in 2024, improving unit economics. The company reported a 42 % year-over-year increase in R&D spend in Q2 2024, reflecting intensified competition from peers such as PsiQuantum and IonQ, which are also pursuing full-stack quantum solutions.
For a deeper quantitative view, you may explore the QUBT analyst dashboard on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-68.4m TTM) > 0 and > 6% of Revenue (6% = 32.8k TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA 23.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 102.4k% (prev 341.4%; Δ 102.1kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -23.1m > Net Income -68.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 154.9 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (166.8m) change vs 12m ago 79.30% (target <= -2.0% for YES) |
| Gross Margin -372.2% (prev -771.4%; Δ 399.2pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.11% (prev 0.56%; Δ -0.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -30.75 (EBITDA TTM -61.9m / Interest Expense TTM 2.15m) >= 6 (WARN >= 3) |
Altman Z'' -8.86
| (A) 0.62 = (Total Current Assets 562.8m - Total Current Liabilities 3.63m) / Total Assets 898.2m |
| (B) -0.24 = Retained Earnings (Balance) -217.6m / Total Assets 898.2m |
| (C) -0.14 = EBIT TTM -66.2m / Avg Total Assets 487.5m |
| (D) -10.71 = Book Value of Equity -217.6m / Total Liabilities 20.3m |
| Total Rating: -8.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.17
| 1. Piotroski 0.0pt |
| 2. FCF Yield -1.44% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda 5.65 |
| 6. ROIC - WACC (= -31.70)% |
| 7. RoE -17.07% |
| 8. Rev. Trend 53.65% |
| 9. EPS Trend 37.46% |
What is the price of QUBT shares?
Over the past week, the price has changed by +8.36%, over one month by +12.69%, over three months by -32.23% and over the past year by +16.73%.
Is QUBT a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the QUBT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | 41.7% |
| Analysts Target Price | 18 | 41.7% |
| ValueRay Target Price | 13.1 | 3.5% |
QUBT Fundamental Data Overview January 17, 2026
P/B = 3.1939
Revenue TTM = 546.0k USD
EBIT TTM = -66.2m USD
EBITDA TTM = -61.9m USD
Long Term Debt = 1.94m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 641.0k USD (from shortTermDebt, last quarter)
Debt = 2.58m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -349.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.18b USD (2.73b + Debt 2.58m - CCE 555.6m)
Interest Coverage Ratio = -30.75 (Ebit TTM -66.2m / Interest Expense TTM 2.15m)
EV/FCF = -69.21x (Enterprise Value 2.18b / FCF TTM -31.5m)
FCF Yield = -1.44% (FCF TTM -31.5m / Enterprise Value 2.18b)
FCF Margin = -5760 % (FCF TTM -31.5m / Revenue TTM 546.0k)
Net Margin = -12.5k% (Net Income TTM -68.4m / Revenue TTM 546.0k)
Gross Margin = -372.2% ((Revenue TTM 546.0k - Cost of Revenue TTM 2.58m) / Revenue TTM)
Gross Margin QoQ = 32.81% (prev 42.62%)
Tobins Q-Ratio = 2.42 (Enterprise Value 2.18b / Total Assets 898.2m)
Interest Expense / Debt = 0.15% (Interest Expense 4000 / Debt 2.58m)
Taxrate = 0.0% (0.0 / 2.36m)
NOPAT = -66.2m (EBIT -66.2m * (1 - 0.00%)) [loss with tax shield]
Current Ratio = 154.9 (out of range, set to none) (Total Current Assets 562.8m / Total Current Liabilities 3.63m)
Debt / Equity = 0.00 (Debt 2.58m / totalStockholderEquity, last quarter 877.9m)
Debt / EBITDA = 5.65 (negative EBITDA) (Net Debt -349.9m / EBITDA -61.9m)
Debt / FCF = 11.12 (negative FCF - burning cash) (Net Debt -349.9m / FCF TTM -31.5m)
Total Stockholder Equity = 400.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.03% (Net Income -68.4m / Total Assets 898.2m)
RoE = -17.07% (Net Income TTM -68.4m / Total Stockholder Equity 400.5m)
RoCE = -16.46% (EBIT -66.2m / Capital Employed (Equity 400.5m + L.T.Debt 1.94m))
RoIC = -16.54% (negative operating profit) (NOPAT -66.2m / Invested Capital 400.5m)
WACC = 15.17% (E(2.73b)/V(2.73b) * Re(15.18%) + D(2.58m)/V(2.73b) * Rd(0.15%) * (1-Tc(0.0)))
Discount Rate = 15.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 46.77%
Fair Price DCF = unknown (Cash Flow -31.5m)
EPS Correlation: 37.46 | EPS CAGR: 176.0% | SUE: 0.44 | # QB: 0
Revenue Correlation: 53.65 | Revenue CAGR: 199.6% | SUE: 3.97 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.17 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+246.3%
Additional Sources for QUBT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle